Oxymetholone (BioDeep_00000003273)

   


代谢物信息卡片


17-Hydroxy-2-(hydroxymethylene)-17-methylandrostan-3-one, (2E,5alpha,17beta)-

化学式: C21H32O3 (332.23513219999995)
中文名称: 康复龙
谱图信息: 最多检出来源 Viridiplantae(plant) 90.91%

分子结构信息

SMILES: CC12CC(=CO)C(=O)CC1CCC1C2CCC2(C)C1CCC2(C)O
InChI: InChI=1S/C21H32O3/c1-19-11-13(12-22)18(23)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,22,24H,4-11H2,1-3H3/b13-12-

描述信息

A - Alimentary tract and metabolism > A14 - Anabolic agents for systemic use > A14A - Anabolic steroids > A14AA - Androstan derivatives
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D045930 - Anabolic Agents
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D000728 - Androgens
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid

同义名列表

4 个代谢物同义名

Oxymetholone; 17-beta-Hydroxy-2-(hydroxymethylene)-17-methyl-5-alpha-androstan-3-one; 17-Hydroxy-2-(hydroxymethylene)-17-methylandrostan-3-one, (2E,5alpha,17beta)-; 434-07-1



数据库引用编号

19 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Jinge Feng, Hongbo Gao, Lin Yang, Yu Xie, Ayman E El-Kenawy, Attalla F El-Kott. Renoprotective and hepatoprotective activity of Lepidium draba L. extracts on oxymetholone-induced oxidative stress in rat. Journal of food biochemistry. 2022 09; 46(9):e14250. doi: 10.1111/jfbc.14250. [PMID: 35633194]
  • Yanbo Wang, Liang Bai, Huiting Li, Wenjun Yang, Min Li. Protective effects of Lepidium draba L. leaves extract on testis histopathology, oxidative stress indicators, serum reproductive hormones and inflammatory signalling in oxymetholone-treated rat. Andrologia. 2021 Dec; 53(11):e14239. doi: 10.1111/and.14239. [PMID: 34520070]
  • Mohsen Akbari Bazm, Nader Goodarzi, Seyed Reza Shahrokhi, Mozafar Khazaei. The effects of hydroalcoholic extract of Vaccinium arctostaphylos L. on sperm parameters, oxidative injury and apoptotic changes in oxymetholone-induced testicular toxicity in mouse. Andrologia. 2020 Apr; 52(3):e13522. doi: 10.1111/and.13522. [PMID: 32012329]
  • Mohsen Akbari Bazm, Mozafar Khazaei, Fatemeh Khazaei, Leila Naseri. Nasturtium Officinale L. hydroalcoholic extract improved oxymetholone-induced oxidative injury in mouse testis and sperm parameters. Andrologia. 2019 Aug; 51(7):e13294. doi: 10.1111/and.13294. [PMID: 31025410]
  • Yen-Ping Lin, Ying-Lin Lee, Chien-Ya Hung, Chuan-Fa Chang, Yi Chen. Detection of adulterated drugs in traditional Chinese medicine and dietary supplements using hydrogen as a carrier gas. PloS one. 2018; 13(10):e0205371. doi: 10.1371/journal.pone.0205371. [PMID: 30304050]
  • Joo Wan Kim, Sae-Kwang Ku, Min Ho Han, Ki Young Kim, Sung Goo Kim, Gi-Young Kim, Hye Jin Hwang, Byung Woo Kim, Cheol Min Kim, Yung Hyun Choi. The administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in mice. International journal of molecular medicine. 2015 Jul; 36(1):29-42. doi: 10.3892/ijmm.2015.2200. [PMID: 25955031]
  • Qianchun Yang, Minawaer Abudou, Xi Sheng Xie, Taixiang Wu. Androgens for the anaemia of chronic kidney disease in adults. The Cochrane database of systematic reviews. 2014 Oct; ?(10):CD006881. doi: 10.1002/14651858.cd006881.pub2. [PMID: 25300168]
  • E Ammatuna, M R Nijziel. Polycythemia and renal infarction in a bodybuilder. QJM : monthly journal of the Association of Physicians. 2014 Aug; 107(8):661-2. doi: 10.1093/qjmed/hcu042. [PMID: 24557731]
  • Tayyebeh Madrakian, Abbas Afkhami, Mohammad Rahimi, Mazaher Ahmadi, Mohammad Soleimani. Preconcentration and spectrophotometric determination of oxymetholone in the presence of its main metabolite (mestanolone) using modified maghemite nanoparticles in urine sample. Talanta. 2013 Oct; 115(?):468-73. doi: 10.1016/j.talanta.2013.05.056. [PMID: 24054620]
  • Tim Sobolevsky, Grigory Rodchenkov. Mass spectrometric description of novel oxymetholone and desoxymethyltestosterone metabolites identified in human urine and their importance for doping control. Drug testing and analysis. 2012 Sep; 4(9):682-91. doi: 10.1002/dta.1407. [PMID: 22945829]
  • Cornelia Fürstenberger, Anna Vuorinen, Thierry Da Cunha, Denise V Kratschmar, Martial Saugy, Daniela Schuster, Alex Odermatt. The anabolic androgenic steroid fluoxymesterone inhibits 11β-hydroxysteroid dehydrogenase 2-dependent glucocorticoid inactivation. Toxicological sciences : an official journal of the Society of Toxicology. 2012 Apr; 126(2):353-61. doi: 10.1093/toxsci/kfs022. [PMID: 22273746]
  • Gordon C Hard, Laura J Betz, John Curtis Seely. Association of advanced chronic progressive nephropathy (CPN) with renal tubule tumors and precursor hyperplasia in control F344 rats from two-year carcinogenicity studies. Toxicologic pathology. 2012 Apr; 40(3):473-81. doi: 10.1177/0192623311431948. [PMID: 22298794]
  • Yasuto Kido, Pär Matsson, Kathleen M Giacomini. Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. Journal of medicinal chemistry. 2011 Jul; 54(13):4548-58. doi: 10.1021/jm2001629. [PMID: 21599003]
  • P Aramwit, S Palapinyo, S Wiwatniwong, O Supasyndh. The efficacy of oxymetholone in combination with erythropoietin on hematologic parameters and muscle mass in CAPD patients. International journal of clinical pharmacology and therapeutics. 2010 Dec; 48(12):803-13. doi: 10.5414/cpp48803. [PMID: 21084036]
  • Hajeong Lee, Jaeseok Yang, Hyosang Kim, Ju Won Kwon, Kook-Hwan Oh, Kwon Wook Joo, Yon Su Kim, Curie Ahn, Jin Suk Han, Suhnggwon Kim. Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously. Journal of Korean medical science. 2010 Nov; 25(11):1676-9. doi: 10.3346/jkms.2010.25.11.1676. [PMID: 21060762]
  • Erkan Ilhan, Deniz Demirci, Tolga Sinan Güvenç, Ali Nazmi Calık. Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir. 2010 Jun; 38(4):275-8. doi: . [PMID: 20935436]
  • Masayuki Yamada, Sugako Aramaki, Masahiko Kurosawa, Koichi Saito, Hiroyuki Nakazawa. Detection of urinary metabolites common to structurally related 17alpha-alkyl anabolic steroids in horses and application to doping tests in racehorses: methandienone, methandriol, and oxymetholone. Journal of analytical toxicology. 2008 Jun; 32(5):387-91. doi: 10.1093/jat/32.5.387. [PMID: 18544225]
  • Aleena Banerji, David E Sloane, Albert L Sheffer. Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2008 Jan; 100(1 Suppl 2):S19-22. doi: 10.1016/s1081-1206(10)60582-0. [PMID: 18220148]
  • Seong-Woo Kim, Jin-Hee Hwang, Jae-Min Cheon, Nam-Sook Park, Sang-Eun Park, Su-Jin Park, Hwan-Jung Yun, Samyong Kim, Deog-Yeon Jo. Direct and indirect effects of androgens on survival of hematopoietic progenitor cells in vitro. Journal of Korean medical science. 2005 Jun; 20(3):409-16. doi: 10.3346/jkms.2005.20.3.409. [PMID: 15953861]
  • Eleni Tholouli, Jo-An Roulson, Richard Byers, Ian Burton, John A Liu Yin. Littoral cell angioma of the spleen in a patient with severe aplastic anaemia. Haematologica. 2003 Nov; 88(11):ECR33. doi: NULL. [PMID: 14607765]
  • Carla Rodrigues Cardoso, Marlice A Sípoli Marques, Ricardo Carvalho Caminha, Maria Christina Maioli, Francisco R Aquino Neto. Validation of the determination of oxymetholone in human plasma analysis using gas chromatography-mass spectrometry. Application to pharmacokinetic studies. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2002 Jul; 775(1):1-8. doi: 10.1016/s1570-0232(02)00243-x. [PMID: 12101054]
  • N A Karrow, J A McCay, R Brown, D Musgrove, A E Munson, K L White. Oxymetholone modulates cell-mediated immunity in male B6C3F1 mice. Drug and chemical toxicology. 2000 Nov; 23(4):621-44. doi: 10.1081/dct-100101974. [PMID: 11071398]
  • R E Stoll, H E Holden, C H Barthel, K T Blanchard. Oxymetholone: III. Evaluation in the p53+/- transgenic mouse model. Toxicologic pathology. 1999 Sep; 27(5):513-8. doi: 10.1177/019262339902700503. [PMID: 10528630]
  • C G Geary, C J Harrison, N J Philpott, J M Hows, E C Gordon-Smith, J C Marsh. Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy. British journal of haematology. 1999 Feb; 104(2):271-4. doi: 10.1046/j.1365-2141.1999.01187.x. [PMID: 10050707]
  • E Vazquez. Comparing Oxandrin and Anadrol-50. Positively aware : the monthly journal of the Test Positive Aware Network. 1998 Jul; 9(4):49-51. doi: . [PMID: 11365632]
  • S Kayashima, T Kondou, Y Watanabe, S Kobari, M Kagami. A patient with non-A, non-B, non-C hepatitis-associated aplastic anemia recovered promptly following immuno-suppressive therapy, including antithymocyte globulin. International journal of hematology. 1998 Jun; 67(4):403-9. doi: 10.1016/s0925-5710(98)00017-6. [PMID: 9695414]
  • S Kulkarni, P S Sastry, T K Saikia, P M Parikh, R Gopal, C N Nair, S H Advani. Antilymphocyte globulin (ALG) or antithymocyte globulin (ATG) with methylprednisone and oxymethalone in aplastic anaemia. The Journal of the Association of Physicians of India. 1997 Apr; 45(4):263-6. doi: . [PMID: 12521080]
  • A S Clark, E V Harrold, A S Fast. Anabolic-androgenic steroid effects on the sexual behavior of intact male rats. Hormones and behavior. 1997 Feb; 31(1):35-46. doi: 10.1006/hbeh.1997.1355. [PMID: 9109597]
  • A Shinagawa, T Itoh, T Komeno, T Komatsu, Y Hasegawa, T Kobayashi, H Kozima, H Ninomiya, T Nagasawa, T Abe. [Allopurinol induced pancytopenia in a patient with myeloproliferative disorder]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 1997 Jan; 38(1):64-71. doi: . [PMID: 9028164]
  • M R Morales-Polanco, E Sánchez-Valle, S Guerrero-Rivera, L Gutiérrez-Alamillo, B Delgado-Márquez. Treatment results of 23 cases of severe aplastic anemia with lymphocytapheresis. Archives of medical research. 1997; 28(1):85-90. doi: . [PMID: 9078593]
  • A Kosaka, H Takahashi, Y Yajima, M Tanaka, K Okamura, R Mizumoto, K Katsuta. Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature. Journal of gastroenterology. 1996 Jun; 31(3):450-4. doi: 10.1007/bf02355039. [PMID: 8726841]
  • A A Welder, J W Robertson, R B Melchert. Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. Journal of pharmacological and toxicological methods. 1995 Aug; 33(4):187-95. doi: 10.1016/1056-8719(94)00073-d. [PMID: 8527826]
  • M Ochocka, M Karwacki, M Matysiak, J Armata, A Dłuzniewska, J Bogusławska-Jaworska, J Pejcz, J Kowalczyk, S Skomra, U Radwańska. [Results of treatment for severe acquired aplastic anemia in children]. Pediatria polska. 1995 Mar; 70(3):205-11. doi: NULL. [PMID: 8657487]
  • A Bacigalupo, M Chaple, J Hows, M T Van Lint, S McCann, D Milligan, J Chessells, A H Goldstone, J Ottolander, E T van't Veer. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party. British journal of haematology. 1993 Jan; 83(1):145-51. doi: 10.1111/j.1365-2141.1993.tb04645.x. [PMID: 8435323]
  • R E Das, A Milne, M Rowley, E C Smith, P M Cotes. Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. British journal of haematology. 1992 Nov; 82(3):601-7. doi: 10.1111/j.1365-2141.1992.tb06474.x. [PMID: 1486041]
  • H Bi, R Massé, G Just. Studies on anabolic steroids. 10. Synthesis and identification of acidic urinary metabolites of oxymetholone in a human. Steroids. 1992 Sep; 57(9):453-9. doi: 10.1016/0039-128x(92)90100-n. [PMID: 1455463]
  • K Doney, M Pepe, R Storb, E Bryant, C Anasetti, F R Appelbaum, C D Buckner, J Sanders, J Singer, K Sullivan. Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. Blood. 1992 May; 79(10):2566-71. doi: . [PMID: 1586708]
  • H Bi, P Du, R Massé. Studies on anabolic steroids--8. GC/MS characterization of unusual seco acidic metabolites of oxymetholone in human urine. The Journal of steroid biochemistry and molecular biology. 1992 Apr; 42(2):229-42. doi: 10.1016/0960-0760(92)90032-e. [PMID: 1567786]
  • M Lekić, M Sober, B Nikolin. [Identification of oxymetholone metabolites in the urine using gas chromatography-mass spectrometry]. Medicinski arhiv. 1992; 46(1-2):5-7. doi: NULL. [PMID: 1345552]
  • R Saxena, O P Malhotra, A K Saraya. A clinico-haematologic profile of paroxysmal nocturnal haemoglobinuria. The Journal of the Association of Physicians of India. 1991 Oct; 39(10):741-3. doi: . [PMID: 1816195]
  • R Massé, H G Bi, C Ayotte, P Du, H Gélinas, R Dugal. Studies on anabolic steroids. V. Sequential reduction of methandienone and structurally related steroid A-ring substituents in humans: gas chromatographic-mass spectrometric study of the corresponding urinary metabolites. Journal of chromatography. 1991 Jan; 562(1-2):323-40. doi: NULL. [PMID: 2026703]
  • A Shibuya, H Ninomiya, M Nakazawa, T Nagasawa, Y Yoda, T Abe. Oxymetholone therapy in patients with familial antithrombin III deficiency. Thrombosis and haemostasis. 1988 Dec; 60(3):495-7. doi: . [PMID: 3238652]
  • K Doney, R Storb, C D Buckner, R McGuffin, R Witherspoon, H J Deeg, F R Appelbaum, K M Sullivan, E D Thomas. Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. Experimental hematology. 1987 Mar; 15(3):239-42. doi: NULL. [PMID: 3493172]
  • J Heresová, R Hampl, L Stárka. [Treatment of gynecomastia with oxymetholone and its excretion in urine]. Ceskoslovenska pediatrie. 1985 Apr; 40(4):224-5. doi: NULL. [PMID: 4017065]
  • M Seip, J Vidnes. Cyclosporine A in a case of refractory severe aplastic anaemia. Scandinavian journal of haematology. 1985 Mar; 34(3):228-30. doi: 10.1111/j.1600-0609.1985.tb02782.x. [PMID: 3992188]
  • R Vilalta, J J Ortega, G Javier, J Tusell. [Acquired aplastic anemia in children. Therapy using androgens and antilymphocyte gamma globulin]. Anales espanoles de pediatria. 1984 Feb; 20(2):91-9. doi: NULL. [PMID: 6370064]
  • K Doney, S J Dahlberg, D Monroe, R Storb, C D Buckner, E D Thomas. Therapy of severe aplastic anemia with anti-human thymocyte globulin and androgens: the effect of HLA-haploidentical marrow infusion. Blood. 1984 Feb; 63(2):342-8. doi: NULL. [PMID: 6362750]
  • K C Doney, B Torok-Storb, S Dahlberg, C D Buckner, P Martin, J A Hansen, E D Thomas, R Storb. Immunosuppressive therapy of severe aplastic anemia. Progress in clinical and biological research. 1984; 148(?):259-70. doi: NULL. [PMID: 6379664]
  • M Griffin, L Coffey, S R McCann. Complete remission of severe aplastic anaemia following treatment with anti-thymocyte globulin. Irish journal of medical science. 1983 Aug; 152(8):313-5. doi: 10.1007/bf02945305. [PMID: 6605326]
  • H Turani, J Levi, D Zevin, E Kessler. Hepatic lesions in patients on anabolic androgenic therapy. Israel journal of medical sciences. 1983 Apr; 19(4):332-7. doi: NULL. [PMID: 6853130]
  • M Beran, G Spitzer, D S Verma. Testosterone and synthetic and androgens improve the in vitro survival of human marrow progenitor cells in serum-free suspension cultures. The Journal of laboratory and clinical medicine. 1982 Feb; 99(2):247-53. doi: . [PMID: 7061919]
  • T L Woodard, G A Burghen, A E Kitabchi, J A Wilimas. Glucose intolerance and insulin resistance in aplastic anemia treated with oxymetholone. The Journal of clinical endocrinology and metabolism. 1981 Nov; 53(5):905-8. doi: 10.1210/jcem-53-5-905. [PMID: 7026595]
  • A L Sheffer, D T Fearon, K F Austen. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. The Journal of allergy and clinical immunology. 1981 Sep; 68(3):181-7. doi: 10.1016/0091-6749(81)90181-0. [PMID: 6790595]
  • D Zevin, H Turani, A Cohen, J Levi. Androgen-associated hepatoma in a hemodialysis patient. Nephron. 1981; 29(5-6):274-6. doi: 10.1159/000182388. [PMID: 6275283]
  • A L Sheffer, D T Fearon, K F Austen. Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema. The Journal of allergy and clinical immunology. 1979 Oct; 64(4):275-80. doi: 10.1016/0091-6749(79)90144-1. [PMID: 479480]
  • P Cornu, B Speck, A Gratwohl, C Nissen, J Sartorius, M Jeannet. [Immunosuppression, bone marrow infusion and low dose androgens, successful therapy of severe aplastic anemia]. Schweizerische medizinische Wochenschrift. 1979 Sep; 109(37):1384-5. doi: NULL. [PMID: 384511]
  • P F Molinari, L L Neri. Effect of a single oral dose of oxymetholone on the metabolism of human erythrocytes. Experimental hematology. 1978 Sep; 6(8):648-54. doi: . [PMID: 710546]
  • J Corkery, M M Bern, J L Tullis. Resolution of amyloidosis and plasma-cell dyscrasia with combination chemotherapy. Lancet (London, England). 1978 Aug; 2(8086):425-6. doi: 10.1016/s0140-6736(78)91895-0. [PMID: 79787]
  • J F Templeton, D F Michiel. Metabolism of 17beta-hydroxy-2-hydroxymethylene-5alpha-androstan-3-one in the rabbit. Steroids. 1978 Jul; 32(1):45-50. doi: 10.1016/0039-128x(78)90098-3. [PMID: 705816]
  • R Alippi, J Giglio, C E Bozzini. Erythrocyte volume and body composition in oxymetholone treated hypophysectomized rats. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 1977 May; 9(3):246-7. doi: 10.1055/s-0028-1095558. [PMID: 885481]
  • J A Napier, I Cavill, C D Dunn, A May, C Ricketts. Oxymetholone treatment in aplastic anaemia: changes in erythropoiesis and serum erythropoietin. British medical journal. 1976 Dec; 2(6049):1426. doi: 10.1136/bmj.2.6049.1426. [PMID: 1009362]
  • R D Reeves, M D Morris, G L Barbour. Hyperlipidemia due to oxymetholone therapy. Occurrence in a long-term hemodialysis patient. JAMA. 1976 Aug; 236(5):469-72. doi: NULL. [PMID: 180304]
  • Z Falda, H Kowalska. [Anapolon-50 in the treatment uremic anemia]. Polskie Archiwum Medycyny Wewnetrznej. 1976 Jan; 55(1):79-87. doi: NULL. [PMID: 1250736]
  • E Amir, Z Oberman, L Laurian, M Herzberg. Proceedings: Hydroxyproline excretion as an assessment of response to treatment with anabolic drugs. Israel journal of medical sciences. 1975 Nov; 11(11):1226. doi: NULL. [PMID: 1205830]
  • I D Walker, J F Davidson, P Young, J A Conkie. Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels. Thrombosis et diathesis haemorrhagica. 1975 Sep; 34(1):106-14. doi: . [PMID: 52896]
  • R Alexanian, J Nadell. Oxymetholone treatment for sickle cell anemia. Blood. 1975 Jun; 45(6):769-77. doi: . [PMID: 1125426]
  • P F Brenner, D R Mishell. A study of the abortifacient effect of oxymetholone in early gestation. Contraception. 1975 Jun; 11(6):669-76. doi: 10.1016/0010-7824(75)90063-3. [PMID: 1137938]
  • R P Wedeen, G A Lipat, B S Morse. Treatment of anemia in chronic hemodialysis patients. The Journal of the Medical Society of New Jersey. 1975 Mar; 72(3):207-11. doi: NULL. [PMID: 1055260]
  • G C Farrell, D E Joshua, R F Uren, P J Baird, K W Perkins, H Kronenberg. Androgen-induced hepatoma. Lancet (London, England). 1975 Feb; 1(7904):430-2. doi: 10.1016/s0140-6736(75)91494-4. [PMID: 48615]
  • D W Cox, W L Heinrichs, A C Paulsen, S H Conrad, H S Schiller, M R Hezl, W L Herrmann. Perturbations of the human menstrual cycle by oxymetholone. American journal of obstetrics and gynecology. 1975 Jan; 121(1):121-6. doi: 10.1016/0002-9378(75)90987-4. [PMID: 1115110]
  • L G Paulo, G D Fink, B L Roh, J W Fisher. Effects of several androgens and steroid metabolites on erythropoietin production in the isolated perfused dog kidney. Blood. 1974 Jan; 43(1):39-47. doi: 10.1182/blood.v43.1.39.39. [PMID: 4809096]
  • B S MacDonald, P J Sykes, B H Kilshaw, R A Harkness. Proceedings: Metabolism of the hydroxymethylene group in the anabolic steroid, oxymetholone: isolation and identification of two major metabolites. The Journal of endocrinology. 1973 Nov; 59(2):18-9. doi: NULL. [PMID: 4759585]
  • Y Harada, Y Okada, T Hikita, T Ninomiya, Y Ishihara. Comparison of growth acceleration of pituitary dwarfs treated with anabolic steroid and thyroid hormone with normal growth spurt. Acta endocrinologica. 1973 Oct; 74(2):237-49. doi: 10.1530/acta.0.0740237. [PMID: 4355073]
  • O H Bolch, J C Warren. Induction of premature menstruation with anabolic steroids. American journal of obstetrics and gynecology. 1973 Sep; 117(1):121-5. doi: 10.1016/0002-9378(73)90738-2. [PMID: 4722368]
  • M C Ede, R G Burr. Circadian rhythm of therapeutic effectiveness of oxymetholone in paraplegic patients. Clinical pharmacology and therapeutics. 1973 May; 14(3):448-54. doi: 10.1002/cpt1973143448. [PMID: 4802684]
  • E L Klaiber, M R Henzl, C W Lloyd, E J Segre. Corpus luteum-inhibiting action of oxymetholone. The Journal of clinical endocrinology and metabolism. 1973 Jan; 36(1):142-7. doi: 10.1210/jcem-36-1-142. [PMID: 4681877]
  • C R Kjeldsberg, H P Ward. Leukemia in arsenic poisoning. Annals of internal medicine. 1972 Dec; 77(6):935-7. doi: 10.7326/0003-4819-77-6-935. [PMID: 4509227]
  • R Alexanian, J Nadell, C Alfrey. Oxymetholone treatment for the anemia of bone marrow failure. Blood. 1972 Sep; 40(3):353-65. doi: 10.1182/blood.v40.3.353.353. [PMID: 5056967]
  • M Davies, T J Muckle, A Cassels-Smith, D Webster, D N Kerr. Oxymetholone in the treatment of anaemia in chronic renal failure. British journal of urology. 1972 Aug; 44(4):387-94. doi: 10.1111/j.1464-410x.1972.tb10097.x. [PMID: 5070142]
  • J N Lukens, L A Neuman. EXcretion and distribution of iron during chronic deferoxamine therapy. Blood. 1971 Nov; 38(5):614-22. doi: 10.1182/blood.v38.5.614.614. [PMID: 5094584]
  • J Barbosa, U S Seal, R P Doe. Effects of anabolic steroids on haptoglobin, orosomucoid, plasminogen, fibrinogen, transferrin, ceruloplasmin, alpha-1-antitrypsin, beta-glucuronidase and total serum proteins. The Journal of clinical endocrinology and metabolism. 1971 Sep; 33(3):388-98. doi: 10.1210/jcem-33-3-388. [PMID: 4105857]
  • Y Nishikawa. [Experimental studies on relation between cholesterol metabolism and endocrine function using C 14 -labelled cholesterol. 2. Effect of endocrine function on plasma and tissue cholesterol levels and C 14 -labelled cholesterol metabolism in the rat]. Naika hokan. Japanese archives of internal medicine. 1971 Sep; 18(9):343-54. doi: NULL. [PMID: 5169517]
  • Y Mishikawa. [Experimental studies on relation between cholesterol metabolism and endocrine function using C 14 -labelled cholesterol. 1. Effect of endocrine function on plasma cholesterol level and C 14 -labelled cholesterol metabolism in the rabbit]. Naika hokan. Japanese archives of internal medicine. 1971 Sep; 18(9):331-41. doi: NULL. [PMID: 5169516]
  • J Barbosa, U S Seal, R P Doe. Effects of anabolic steroids on hormone-binding proteins, serum cortisol and serum nonprotein-bound cortisol. The Journal of clinical endocrinology and metabolism. 1971 Feb; 32(2):232-40. doi: 10.1210/jcem-32-2-232. [PMID: 4992507]
  • P M Adhikary, R A Harkness. The use of carbon skeleton chromatography for the detection of steroid drug metabolites: the metabolism of anabolic steroids in man. Acta endocrinologica. 1971; 67(4):721-32. doi: 10.1530/acta.0.0670721. [PMID: 5109144]
  • K B McCredie. Oxymetholone in refractory anaemia. British journal of haematology. 1969 Sep; 17(3):265-73. doi: 10.1111/j.1365-2141.1969.tb01372.x. [PMID: 5806436]
  • Y Sako. [Clinical studies on the stimulation and suppression of the pituitary-adrenocortical system. 3. Studies on the pituitary adrenocortical suppression after long-term glucocorticoid treatment]. Nihon Naibunpi Gakkai zasshi. 1968 Dec; 44(9):1025-36. doi: 10.1507/endocrine1927.44.9_1025. [PMID: 4304529]
  • A J Rosin, H E Farran. Factors influencing in vitro tests of thyroid function in the elderly. Journal of the American Geriatrics Society. 1968 Sep; 16(9):1030-8. doi: 10.1111/j.1532-5415.1968.tb02733.x. [PMID: 4174490]
  • H Takayasu, Y Kumamoto, K Kinoshita, K Isurugi, M Yokoyama. [Administration of an anabolic steroid for the wandering kidney]. Saishin igaku. Modern medicine. 1968 Jul; 23(7):1455-9. doi: NULL. [PMID: 5706927]
  • K Hamamoto. [Clinical studies on protein and water metabolism by using isotopes. 2. Studies on the mechanism of action of anabolic steroids using 131-I-labeled human serum albumin]. Nihon Naibunpi Gakkai zasshi. 1967 May; 43(2):131-42. doi: 10.1507/endocrine1927.43.2_131. [PMID: 6069760]
  • T Saito, M Saito. [Studies on the mechanism of action of anabolic steroids. 2. Effect on serum glycoproteins]. Iryo. 1966 Nov; 20(11):1154-61. doi: NULL. [PMID: 5982058]
  • T Nagashima, K Seimiya, M Suda, H Kawakami. [Hepatitis caused by preserved plasma and anabolic steriods]. Iryo. 1966 Apr; 20(4):386-91. doi: NULL. [PMID: 5974198]
  • G Fiegel, R Bargheer, D Kukwa. [The behavior of lipid metabolism under the effect of simultaneous administration of anabolics and essential phospholipids]. Arzneimittel-Forschung. 1966 Mar; 16(3):443-6. doi: ". [PMID: 6013856]
  • G Fiegel, R Bargheer, D Kukwa. [Modification of lipid metabolism by anabolic agents]. Arzneimittel-Forschung. 1966 Feb; 16(2):202-6. doi: ". [PMID: 6014014]
  • D N OLVEY, R E CUTLER, J T DOWLING. THYROXINE-BINDING BY THE THROXINE-BINDING GLOBULIN AS A MEASURE OF THE ANABOLIC ACTIVITY OF CONGENERS OF TESTOSTERONE. Metabolism: clinical and experimental. 1965 Aug; 14(?):891-8. doi: 10.1016/0026-0495(65)90127-7. [PMID: 14320977]
  • Y YOSHITOSHI. [THE METABOLIC EFFECT OF ANABOLIC STEROIDS AND THEIR CLINICAL APPLICATION]. Nihon Naibunpi Gakkai zasshi. 1964 Dec; 40(?):1155-65. doi: NULL. [PMID: 14267839]
  • F M ANTONINI, G VERDI. [Research on a new synthetic anabolic steroid: oxymetholone. Behavior of some lipid fractions of the serum]. Giornale di gerontologia. 1961 Nov; 9(?):1051-65. doi: NULL. [PMID: 13861811]